Pyrimidine compounds
AssigneeAstraZeneca AB
InventorsElizabeth Janet Pease, Gloria Anne Breault, Robert Hugh Bradbury
Life of this patent
Estimating the term…
Abstract
Pyrimidine derivatives of the formula (I) wherein: one of Q1 and Q2 or both of Q1 and Q2 is substituted on a ring carbon by one substituent of the formula (Ia) [provided that when present in Q1 the substituent of formula (Ia) is not adjacent to the —NH— link]; wherein Q1, Q2, G, R1, X, Y1, Y2, Z, n and m are as described within; and pharmaceutically acceptable salts and in vivo hydrolysable esters thereof are described. Processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine/threonine kinase (CDK) and focal adhesion kinase (FAK) inhibitors are also described. 1
Claims16
A pyrimidine derivative of the formula (I):
- 33
- wherein:
- Q1 and Q2 are independently selected from aryl or carbon linked heteroaryl;
- and one of Q1 and Q2 or both of Q1 and Q2 is substituted on a ring carbon by one substituent of the formula (Ia):
- 34
- [provided that when present in Q1 the substituent of formula (Ia) is not adjacent to the —NH— link];
- wherein:
- X is —CH2—, —O—, —NH—, —NRa— or —S— [wherein Ra is C1-4alkyl, optionally substituted by one substituent selected from halo, amino, cyano, C1-4alkoxy or hydroxy];
- Y1 is H, C1-4alkyl or as defined for Z;
- Y2 is H or C1-4alkyl;
- Z is RbO—, RcRdN—, ReS—, RfRgNNRh—, a nitrogen linked heteroaryl or a nitrogen linked heterocycle [wherein said heterocycle is optionally substituted on a ring carbon or a ring nitrogen by C1-4alkyl or C1-4alkanoyl] wherein Rb, Rc, Rd, Re, Rf, Rg and Rh are independently selected from hydrogen, C1-4alkyl, C2-4alkenyl, C3-8cycloalkyl, and wherein said C1-4alkyl and C2-4alkenyl are optionally substituted by one or more phenyl;
- n is 1, 2 or 3;
- mis 1, 2 or 3;
- G is —O— or —S—;
- R1 is selected from hydrogen, halo, hydroxy, nitro, amino, N—(C1-3alkyl)amino, N,N-di-(C1-3alkyl)amino, cyano, trifluoromethyl, trichloromethyl, C1-3alkyl [optionally substituted by 1 or 2 substituents independently selected from halo, cyano, amino, N—(C1-3alkyl)amino, N,N-di-(C1-3alkyl)amino, hydroxy and trifluoromethyl], C3-5alkenyl [optionally substituted by up to three halo substituents, or by one trifluoromethyl substituent], C3-5alkynyl, C1-3alkoxy, mercapto, C1-3alkylsulphanyl, carboxy and C1-3alkoxycarbonyl;
- Q1 is optionally substituted on a ring carbon by one to four substituents independently selected from halo, mercapto, nitro, formyl, formamido, carboxy, cyano, amino, ureido, carbamoyl, sulphamoyl, C1-4alkyl, C2-4alkenyl, C2-4alkynyl [wherein said C1-4alkyl, C2-4alkenyl and C2-4alkynyl are optionally substituted by one or more groups selected from Ri], C1-4alkanoyl, C1-4alkoxycarbonyl, heterocyclic group, C1-4alkylS(O)a wherein a is 0 to 2 [optionally substituted by hydroxy], N′—(C1-4alkyl)ureido, N′,N′-di-(C1-4alkyl)ureido, N—(C1-4alkyl)-N—(C1-4alkyl)ureido, N′,N′-di-(C1-4alkyl)-N—(C1-4alkyl)ureido, N—C1-4alkylamino, N,N-di-(C1-4alkyl)amino, N—(C1-4alkyl)sulphamoyl, N,N-di-(C1-4alkyl)sulphamoyl, N—C1-4alkylcarbamoyl, N,N-di-(C1-4alkyl)carbamoyl and C1-4alkanoylamino;
- and also independently, or in addition to, the above substituents, Q1 may be optionally substituted by one to two substituents independently selected from aryl, C3-8cycloalkyl and a heterocyclic group;
- wherein said aryl, C3-8cycloalkyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from Rj;
- and wherein if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from Rk;
- Q2 is optionally substituted on a ring carbon by one to four substituents independently selected from halo, hydroxy, mercapto, nitro, formyl, formamido, carboxy, cyano, amino, ureido, carbamoyl, sulphamoyl, C1-4alkyl, C2-4alkenyl, C2-4alkynyl, C1-4alkoxy [wherein said C1-4alkyl, C2-4alkenyl, C2-4alkynyl and C1-4alkoxy are optionally substituted by one or more groups selected from R1], C1-4alkanoyl, C1-4alkoxycarbonyl, heterocyclic group, C1-4alkylS(O)a wherein a is 0 to 2 [optionally substituted by hydroxy], N′—(C1-4alkyl)ureido, N′,N′-di-(C1-4alkyl)ureido, N′-(C1-4alkyl)-N—(C1-4alkyl)ureido, N′,N′-di-(C1-4alkyl)-N—(C1-4alkyl)ureido, N—C1-4alkylamino, N,N-di-(C1-4alkyl)amino, N—(C1-4alkyl)sulphamoyl, N,N-di-(C1-4alkyl)sulphamoyl, N—C1-4alkylcarbamoyl, N,N-di-(C4alkyl)carbamoyl, C2-4alkenyloxy, C1-4alkynyloxy, C1-4alkanoylamino and a group of formula (Ia) or (Ia′) as depicted above;
- and also independently, or in addition to, the above substituents, Q2 may be optionally substituted by one to two substituents independently selected from aryl, C3-8cycloalkyl or a heterocyclic group;
- wherein said aryl, C3-8cycloalkyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from Rm;
- and wherein if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from Rn;
- Ri and R1 are independently selected from hydroxy, halo, amino, cyano, formyl, formamido, carboxy, nitro, mercapto, carbamoyl, sulphamoyl, N—C1-4alkylamino, N,N-di-(C1-4alkyl)amino, C1-4alkanoyl, C1-4alkanoyloxy, C1-4alkoxy, C1-4alkoxycarbonyl, N—C1-4alkylcarbamoyl, N,N-di-(C1-4alkyl)carbamoyl, C1-4alkanoylamino, C1-4alkylS(O)a wherein a is 0 to 2, C1-4alkylsulphonylamino, N—(C1-4alkyl)sulphamoyl, N—(C1-4alkyl)2sulphamoyl, N—(C1-4alkyl)carbamoyl, N—(C1-4alkyl)2carbamoyl, phenyl, phenylthio, phenoxy, C3-8cycloalkyl and a heterocyclic group;
- wherein said phenyl, phenylthio, phenoxy, C3-8cycloalkyl or heterocyclic group may be optionally substituted on a ring carbon by one or more groups selected from TV;
- and wherein if said heterocyclic group contains an —NH— moiety that nitrogen may be optionally substituted by a group selected from Rp;
- Rj, Rm and Ro are independently selected from hydroxy, halo, amino, cyano, formyl, formamido, carboxy, nitro, mercapto, carbamoyl, sulphamoyl, C1-4alkyl [optionally substituted by one or more groups selected from halo, cyano, amino, N—C1-4alkylamino, N,N-di-(C1-4alkyl)amino or hydroxy], C2-4alkenyl [optionally substituted by one or more groups selected from halo], C2-4alkynyl, N—C1-4alkylamino, N,N-di-(C1-4alkyl)amino, C1-4alkanoyl, C1-4alkanoyloxy, C1-4alkoxy [optionally substituted by one or more groups selected from halo], C1-4alkoxycarbonyl, N—C1-4alkylcarbamoyl, N,N-di-(C1-4alkyl)carbamoyl, C1-4alkanoylamino, C1-4alkylS(O)a wherein a is 0 to 2, C1-4alkylsulphonylamino, N—(C1-4alkyl)sulphamoyl, N—(C1-4alkyl)2sulphamoyl, phenyl, C3-8cycloalkyl and a heterocyclic group;
- and
- Rk, Rn and Rp are independently selected from C1-4alkyl, C1-4alkanoyl, C1-4alkylsulphonyl, C1-4alkoxycarbonyl, carbamoyl, N—(C1-4alkyl)carbamoyl, N,N—(C1-4alkyl)carbamoyl, benzyl, benzyloxycarbonyl, benzoyl and phenylsulphonyl;
- or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof.
Dependencies are inferred from the claim text.